NEW YORK (GenomeWeb) – Great Basin announced today that its Bordetella Direct assay has received CE Marking.

The PCR-based test to detect Bordetella pertussis was granted 510(k) clearance by the US Food and Drug Administration earlier this year and will now be launched commercially.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.